Don L Gibbons

52PUBLICATIONS
489CO-AUTHORS
Molecular targetsPredictive and prognostic markersGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 27, 2026
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

|Jun 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Feb 25, 2026
Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.

Natalie K Horvat, Myritney Saint-Cloud, Raihaanah Bint Abdullah Muslim

Pageof 9

Frequent Collaborators

37 joint publications

John Victor Heymach

29 joint publications

Jianjun Zhang

19 joint publications

Jack Lee

17 joint publications

Tina Cascone